Jfl Life Sciences Limited — Board Meeting, 19-05-2025: Outcome of Board Meeting

JFL Life Sciences has announced a board meeting approving audited financial results for FY25. Consolidated revenue stood at Rs 173.38 Cr with a net profit of Rs 8.36 Cr. Despite a dip in operating cash flow due to working capital, capex was moderate at Rs 3.95 Cr. The board approved a dividend payout of Rs 2.75 Cr. The company reduced borrowings and maintained stable cash, reflecting steady growth and disciplined financial management.